Author:
Schättler Heinz,Ledzewicz Urszula
Reference37 articles.
1. K. Alitalo, Amplification of cellular oncogenes in cancer cells, Trends Biochemical Science, 10 (1985), pp. 194–197.
2. J. Bellmunt, J.M. Trigo, E. Calvo, J. Carles, J.L. Pérez-Garcia, J.A. Virizuela, R. Lopez, M. Lázaro and J. Albanell, Activity of a multi-targeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase-2 study (SOGUG-02-06), Lancet Oncology, 2010.
3. A.J. Coldman and J.H. Goldie, A model for the resistance of tumor cells to cancer chemotherapeutic agents, Mathematical Biosciences, 65, (1983), pp. 291–307.
4. A.J. Coldman and J.H. Goldie, A stochastic model for the origin and treatment of tumors containing drug-resistant cells, Bulletin of Mathematical Biology, 48, (1986), pp. 279–292.G
5. M.I.S. Costa, J.L. Boldrini and R.C. Bassanezi, Drug kinetics and drug resistance in optimal chemotherapy, Mathematical Biosciences, 125, (1995), pp. 191–209.